Successful continuous nivolumab therapy for metastatic non‐small cell lung cancer after local treatment of oligometastatic lesions

Abstract The patient in this report was a 57‐year‐old man with metastatic non‐small cell lung cancer (NSCLC). After no response to two lines of systemic chemotherapy, he was treated with nivolumab as third‐line therapy, which resulted in a partial response. After 17 months of nivolumab treatment, he...

Full description

Bibliographic Details
Main Authors: Satoshi Tobita, Yuhei Kinehara, Yoshio Tamura, Hiroyuki Kurebe, Ryusuke Ninomiya, Yoshihiko Utsu, Satoshi Kohmo, Bunzo Sato, Kenichi Nagai, Shintaro Maruoka, Ryu Jokoji, Shohei Koyama, Isao Tachibana
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.13539